133 related articles for article (PubMed ID: 18776235)
1. LNA incorporated siRNAs exhibit lower off-target effects compared to 2'-OMethoxy in cell phenotypic assays and microarray analysis.
Puri N; Wang X; Varma R; Burnett C; Beauchamp L; Batten DM; Young M; Sule V; Latham K; Sendera T; Echeverri C; Sachse C; Magdaleno S
Nucleic Acids Symp Ser (Oxf); 2008; (52):25-6. PubMed ID: 18776235
[TBL] [Abstract][Full Text] [Related]
2. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.
Elmén J; Thonberg H; Ljungberg K; Frieden M; Westergaard M; Xu Y; Wahren B; Liang Z; Ørum H; Koch T; Wahlestedt C
Nucleic Acids Res; 2005; 33(1):439-47. PubMed ID: 15653644
[TBL] [Abstract][Full Text] [Related]
3. Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3.
Dutkiewicz M; Grunert HP; Zeichhardt H; Lena SW; Wengel J; Kurreck J
FEBS Lett; 2008 Sep; 582(20):3061-6. PubMed ID: 18691577
[TBL] [Abstract][Full Text] [Related]
4. High-content imaging analysis of the knockdown effects of validated siRNAs and antisense oligonucleotides.
Low J; Shuguang Huang ; Dowless M; Blosser W; Vincent T; Davis S; Hodson J; Koller E; Marcusson E; Blanchard K; Stancato L
J Biomol Screen; 2007 Sep; 12(6):775-88. PubMed ID: 17517903
[TBL] [Abstract][Full Text] [Related]
5. Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo.
Laursen MB; Pakula MM; Gao S; Fluiter K; Mook OR; Baas F; Langklaer N; Wengel SL; Wengel J; Kjems J; Bramsen JB
Mol Biosyst; 2010 May; 6(5):862-70. PubMed ID: 20567772
[TBL] [Abstract][Full Text] [Related]
6. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
[TBL] [Abstract][Full Text] [Related]
7. RNAi microarray analysis in cultured mammalian cells.
Mousses S; Caplen NJ; Cornelison R; Weaver D; Basik M; Hautaniemi S; Elkahloun AG; Lotufo RA; Choudary A; Dougherty ER; Suh E; Kallioniemi O
Genome Res; 2003 Oct; 13(10):2341-7. PubMed ID: 14525932
[TBL] [Abstract][Full Text] [Related]
8. Identification of sequence features that predict competition potency of siRNAs.
Li X; Yoo JW; Lee JH; Hahn Y; Kim S; Lee DK
Biochem Biophys Res Commun; 2010 Jul; 398(1):92-7. PubMed ID: 20558136
[TBL] [Abstract][Full Text] [Related]
9. Study of modification pattern-RNAi activity relationships by using siRNAs modified with 4'-thioribonucleosides.
Hoshika S; Minakawa N; Shionoya A; Imada K; Ogawa N; Matsuda A
Chembiochem; 2007 Nov; 8(17):2133-8. PubMed ID: 17924376
[TBL] [Abstract][Full Text] [Related]
10. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects.
Cekaite L; Furset G; Hovig E; Sioud M
J Mol Biol; 2007 Jan; 365(1):90-108. PubMed ID: 17054988
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.
Iwase R; Miyao H; Toyama T; Nishimori K
Nucleic Acids Symp Ser (Oxf); 2006; (50):175-6. PubMed ID: 17150874
[TBL] [Abstract][Full Text] [Related]
13. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence.
Fluiter K; Mook OR; Baas F
Methods Mol Biol; 2009; 487():189-203. PubMed ID: 19301648
[TBL] [Abstract][Full Text] [Related]
15. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
16. On the art of identifying effective and specific siRNAs.
Pei Y; Tuschl T
Nat Methods; 2006 Sep; 3(9):670-6. PubMed ID: 16929310
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling reveals off-target gene regulation by RNAi.
Jackson AL; Bartz SR; Schelter J; Kobayashi SV; Burchard J; Mao M; Li B; Cavet G; Linsley PS
Nat Biotechnol; 2003 Jun; 21(6):635-7. PubMed ID: 12754523
[TBL] [Abstract][Full Text] [Related]
18. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
19. Identifying siRNA-induced off-targets by microarray analysis.
Anderson E; Boese Q; Khvorova A; Karpilow J
Methods Mol Biol; 2008; 442():45-63. PubMed ID: 18369777
[TBL] [Abstract][Full Text] [Related]
20. An siRNA designing tool with a unique functional off-target filtering approach.
Das S; Ghosal S; Kozak K; Chakrabarti J
J Biomol Struct Dyn; 2013; 31(11):1343-57. PubMed ID: 23140209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
